| Market Cap | ₹2,712Cr | 
| ROE | -5.22% | 
| P/E Ratio(TTM) | 243.24 | 
| EPS(TTM) | 1.82 | 
| P/B Ratio | 3.33 | 
| Dividend Yield | 0.00% | 
| Industry P/E | 34.73 | 
| Book Value | 132.75 | 
| Debt to Equity | 0.03 | 
| Face Value | 1 | 
| Parent Organisation | Panacea Biotec | 
| Managing Director | Dr. Rajesh Jain | 
| NSE Symbol | PANACEABIO | 
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Biocon | NA (0.00%) | 76.08 | ||
| Anthem Biosciences | NA (0.00%) | 90.40 | ||
| Onesource Specialty Pharma | NA (0.00%) | -1684.41 | ||
| Advanced Enzyme Technologies | NA (0.00%) | 24.81 |